Genes

BIO5 member Deepta Bhattacharya is part of a University of Arizona research team developing gene-edited stem cells designed to avoid immune rejection, a breakthrough that could enable cell therapies for Type 1 diabetes without lifelong anti-rejection drugs.

Dr. Teodora Georgieva and the GEMM Core Facility at the University of Arizona BIO5 Institute design models for science to advance the discovery of novel therapeutics.

BIO5 member Vlad Kalinichenko is helping lead the new Phoenix Children’s Research Institute, a partnership between the University of Arizona College of Medicine – Phoenix and Phoenix Children’s.